Allarity Therapeutics (ALLR) Asset Writedowns and Impairment (2022 - 2024)
Allarity Therapeutics' (ALLR) quarterly Asset Writedowns and Impairment came in at -$3000.0 in Q4 2024, down 100.27% YoY from $1.1 million in Q1 2024, and down 100.03% on a QoQ basis from $9.6 million in Q3 2024.
Allarity Therapeutics (ALLR) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 3 years of Asset Writedowns and Impairment data on file, last reported at -$3000.0 in Q4 2024.
- Quarterly Asset Writedowns and Impairment fell 100.27% year-over-year to -$3000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $9.6 million (down 0.99% YoY) and the FY2024 annual result came in at $9.7 million, up 773.87% from the prior year.
- Asset Writedowns and Impairment slipped to -$3000.0 in Q4 2024, from $9.6 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $14.0 million in Q1 2022 to a low of -$200000.0 in Q3 2023.
- A 3-year average of $2.8 million and a median of $106500.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 4893.5% in 2024, down 100.27% in 2024.
- Tracing ALLR's Asset Writedowns and Impairment over 3 years: stood at $3.6 million in 2022, then slumped by 68.86% to $1.1 million in 2023, then tumbled by 100.27% to -$3000.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at -$3000.0 (Q4 2024), $9.6 million (Q3 2024), and $20000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 9.59 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | -200,000.00 |
| Sep 30, 2023 | -200,000.00 |
| Jun 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 117,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Dec 31, 2022 | 3.56 Mn |
| Dec 31, 2022 | 3.56 Mn |
| Mar 31, 2022 | 14.01 Mn |
| Mar 31, 2022 | 14.01 Mn |